Psychological Distress as a Negative Survival Factor for Patients with Hematologic Malignancies Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation

被引:12
|
作者
Park, Ji Eun [1 ]
Kim, Kyung Im [1 ]
Yoon, Sung Soo [2 ]
Hahm, Bong Jin [3 ]
Lee, Sang Min [1 ]
Yoon, Jeong Hyun [5 ]
Shin, Wan Gyoon [1 ]
Lee, Hye Suk [4 ]
Oh, Jung Mi [1 ]
机构
[1] Seoul Natl Univ, Dept Clin Pharm, Coll Pharm, Seoul 151742, South Korea
[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[3] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea
[4] Seoul Natl Univ Hosp, Dept Pharm, Seoul 110744, South Korea
[5] Pusan Natl Univ, Dept Clin Pharm, Coll Pharm, Pusan 609735, South Korea
来源
PHARMACOTHERAPY | 2010年 / 30卷 / 12期
关键词
psychological stress; distress; hematopoietic stem cell transplantation; hematologic malignancy; survival; BONE-MARROW-TRANSPLANTATION; UMBILICAL-CORD BLOOD; ACUTE MYELOID-LEUKEMIA; SYMPTOM DISTRESS; RISK-FACTOR; DEPRESSION; MORTALITY; IMPACT; ADULTS; ASSOCIATION;
D O I
10.1592/phco.30.12.1239
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective To evaluate the influence of distress on overall survival of patients with hematologic malignancies who underwent allogeneic stem cell transplantation (allo-SCT) and to analyze the possible risk factors for death Design Retrospective cohort study Setting Large tertiary care teaching hospital Patients Seventy-seven patients (aged >= 15 yrs) with hematologic malignancies who underwent allo-SCT between January 2000 and August 2007, 20 patients with distress history were matched in a 1 3 ratio with 57 patients without distress history Measurements and Main Results The primary outcome was overall survival, defined as the time from allo-SCT to disease-related death or last date of follow-up Secondary outcomes were time to hematologic recovery (absolute neutrophil count >= 500 cells/mm(3)) from day of allo-SCT, length of hospital stay, and opioid usage Sociodemographic information and clinical characteristics were analyzed for possible risk factors Patient history of psychological distress resulted in a significantly higher mortality rate in the first year after allo-SCT (hazard ratio [HR] 3 05, 95% confidence interval [CI] 1 48-6 28, p=0 001) and led to a shorter overall survival rate (HR 1 63, 95% CI 0 86-3 10 p=0 133) However, psychological distress had no effect on hospital length of stay, hematologic recovery time, opioid usage status, or dose of opioid analgesics used Factors associated with death after allo-SCT in the univariate analysis (p<0 05) were high-relapse risk disease, umbilical cord blood SCT, total-body irradiation-containing conditioning regimen, and higher educational background In the multivariate analysis, high relapse risk (HR 3 85, 95% CI 1 81-8 20, p<0 001) and total-body irradiation-containing conditioning regimen (HR 3 50, 95% CI 1 29-9 51, p=0 01) were identified as risk factors for death Conclusion A history of psychological distress before allo-SCT, after adjusting for other patient- and disease-related prognostic factors, had a significant influence on early death in the first year after transplantation
引用
收藏
页码:1239 / 1246
页数:8
相关论文
共 50 条
  • [31] Clinical observation of patients with hematologic malignancies treated with hematopoietic stem cell transplantation
    Zhang Donghua
    Zhang Lu
    Xiao Yi
    Huang Wei
    Li Dengju
    Ran Dan
    Huang Liang
    Zhou Jianfeng
    Huang Mei
    Sun Hanying
    Liu Wenli
    Current Medical Science, 2004, 24 (4) : 345 - 349
  • [32] Coping in caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation
    Amonoo, Hermioni L.
    Johnson, P. Connor
    Nelson, Ashley M.
    Clay, Madison A.
    Daskalakis, Elizabeth
    Newcomb, Richard A.
    Deary, Emma C.
    Mattera, Elizabeth F.
    Yang, Daniel
    Cronin, Katherine
    Lee, Stephanie J.
    LeBlanc, Thomas W.
    El-Jawahri, Areej
    BLOOD ADVANCES, 2023, 7 (07) : 1108 - 1116
  • [33] Molecular Profile and Dynamics of Commensal Viruses in Brazilian Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
    de Campos, Gabriel Montenegro
    Costa, Thalita Cristina de Mello
    da Silva, Anielly Sarana
    Costa, Lara Okuyama Afonso
    Silveira, Roberta Maraninchi
    Valenca, Ian Nunes
    de Carvalho, Felipe Santos
    Darrigo Jr, Luiz Guilherme
    Haddad, Rodrigo
    Vieira, Ana Carolina de Jesus
    Mesquita, Camila Campos
    Laurindo, Patricia da Silva
    Cunha, Renato Guerino
    Alcantara, Luiz Carlos Junior
    Kashima, Simone
    Covas, Dimas Tadeu
    Simoes, Belinda Pinto
    Sampaio, Sandra Coccuzzo
    Elias, Maria Carolina
    Giovanetti, Marta
    Junqueira, Dennis Maletich
    Slavov, Svetoslav Nanev
    TRANSPLANT INFECTIOUS DISEASE, 2025,
  • [34] Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades
    Ohbiki, Marie
    Ito, Yuri
    Inamoto, Yoshihiro
    Miyamura, Koichi
    Uchida, Naoyuki
    Fukuda, Takahiro
    Fujiwara, Hiroki
    Nishida, Tetsuya
    Hayashi, Masayasu
    Tanaka, Masatsugu
    Kawakita, Toshiro
    Ikegame, Kazuhiro
    Katayama, Yuta
    Ara, Takahide
    Ichinohe, Tatsuo
    Kiyoi, Hitoshi
    Matsuo, Keitaro
    Atsuta, Yoshiko
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (12): : 768.e1 - 768.e10
  • [35] Effect of body mass index on overall survival of patients with allogeneic hematopoietic stem cell transplantation
    Yang, J.
    Xue, S-L
    Zhang, X.
    Zhou, Y-N
    Qin, L-Q
    Shen, Y-P
    Wu, D-P
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2017, 71 (06) : 750 - 754
  • [36] Squamous cell carcinoma development in Fanconi anemia patients who underwent hematopoietic stem cell transplantation
    Anak, Sema
    Yalman, Nevin
    Bilgen, Hulya
    Sepet, Elif
    Deviren, Ayhan
    Gurtekin, Basak
    Tunca, Fatih
    Basaran, Bora
    PEDIATRIC TRANSPLANTATION, 2020, 24 (04)
  • [37] Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic Malignancies
    Hsu, Jingmei
    Chen, Zhengming
    Shore, Tsiporah
    Gergis, Usama
    Mayer, Sebastian
    Phillips, Adrienne
    Guarner, Danielle
    Hsu, Yen-Michael
    Cushing, Melissa M.
    Van Besien, Koen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (04) : 789 - 797
  • [38] Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignancies
    Liu, Hongtao
    Stock, Wendy
    Bishop, Michael R.
    CURRENT OPINION IN HEMATOLOGY, 2013, 20 (02) : 115 - 122
  • [39] Anxiety and Depression of the Patients with Hematological Malignancies during Hospitalization for Hematopoietic Stem Cell Transplantation
    Seo, Ho-Jun
    Baek, Young-Gun
    Cho, Byung-Sik
    Kim, Tae-Suk
    Um, Yoo Hyun
    Chae, Jeong-Ho
    PSYCHIATRY INVESTIGATION, 2019, 16 (10) : 751 - 758
  • [40] The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
    Wang, Limengmeng
    Xiao, Haowen
    Zhang, Xing
    Wang, Chong
    Huang, He
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7